The zebrafish has become a powerful tool for analysis of vertebrate hematopoiesis. Zebrafish, unlike mammals, have a robust primitive myeloid pathway that generates both granulocytes and macrophages. It is not clear how this unique primitive myeloid pathway relates to mammalian definitive hematopoiesis. In this study, we show that the two myeloid subsets can be distinguished using RNA in situ hybridization. Using a morpholino-antisense gene knockdown approach, we have characterized the hematopoietic defects resulting from knockdown of the myeloid transcription factor gene pu.1 and the unique zebrafish gene c=ebp1. Severe reduction of pu.1 resulted in complete loss of primitive macrophage development, with effects on granulocyte development only with maximal knockdown. Reduction of c=ebp1 did not ablate initial macrophage or granulocyte development, but resulted in loss of expression of the secondary granule gene lys C. These data reveal strong functional conservation of pu.1 between zebrafish primitive myelopoiesis and mammalian definitive myelopoiesis. Further, these results are consistent with a conserved role between c=ebp1 and mammalian C=EBPE, whose ortholog in zebrafish has not been identified. These studies validate the examination of zebrafish primitive myeloid development as a model for human myelopoiesis, and form a framework for identification and analysis of myeloid mutants.
Introduction

I
n mammals, myelopoiesis occurs during definitive hematopoiesis, through progressive commitment and differentiation steps from pluripotent hematopoietic stem cells to common myeloid progenitors that ultimately generate terminally differentiated erythroid, granulocyte, and macrophage=monocyte lineages. The genes that direct this process, including scl, spi-1=pu.1 (hereafter called pu.1), c=ebps, and gata1, have been shown to play important roles not only in normal hematopoiesis but also in leukemogenesis. [1] [2] [3] [4] [5] Zebrafish have become a powerful vertebrate model for analyses of hematopoiesis. Due to the easy visibility of erythroid cells, over 26 hematopoietic mutants with abnormalities in erythroid populations have been identified. 6 The cloning of the genes mutated in these defects has identified both known and novel genes required for stem cell development, and development and=or maintenance of the erythroid lineage. 7, 8 In contrast to the early hematopoietic screens that successfully identified alterations in erythropoiesis, mutagenesis screens to analyze myeloid deficiencies are in the early stages. The ability to design directed screens for myeloid defects requires a better understanding of normal myelopoiesis in the zebrafish.
Zebrafish develop both macrophages and granulocytes during primitive hematopoiesis, while mammals generate largely erythroid cells, with a small number of primitive macrophages and no granulocytes, during primitive hematopoiesis. [9] [10] [11] [12] Due to the ease of examining early events in the zebrafish, primitive myelopoiesis is being used in most screens to assess myelopoiesis, although the parallels that can be drawn between primitive myelopoiesis in zebrafish and definitive myelopoiesis in mammals are not known.
In the zebrafish, early markers of hematopoiesis are first evident by the 1-3 somite stage or 11 hours postfertilization (hpf ) in two regions, the anterior lateral mesoderm (ALM) region near the head and the posterior lateral mesoderm (PLM), which later forms the intermediate cell mass (ICM). 13 Erythroid development takes place in the PLM=ICM, while macrophages develop from the ALM 10 and granulocytes may develop from the ALM and PLM. 9, 11 Transcription factors essential for myeloid development in mammals include PU.1 and a number of C=EBP family members. PU.1 is an Ets-family transcription factor known to be essential for macrophage and B lymphoid development and some aspects of granulocyte differentiation in mammals. 14, 15 The C=EBP family of transcription factors includes several members involved in hematopoietic development. Orthologs of C=ebpa and C=ebpb have been identified in the zebrafish. 16 Interestingly, an ortholog for C=ebpe, required for terminal maturation of granulocytes and expression of secondary granule proteins in mammals, has not been identified in the zebrafish. However, another C=ebp family member, C=ebp1, was identified in zebrafish and is expressed specifically in myeloid cells. 17 The functional role of C=ebp1 in myeloid development has not yet been explored. Here we characterize the myeloid subsets present during primitive hematopoiesis and examine the functional roles of Pu.1 and C=ebp1 through a morpholino (MO)-based knockdown approach.
Results
Two myeloid subsets can be distinguished in primitive zebrafish hematopoiesis
To characterize the myeloid cell populations present in zebrafish embryos, whole-mount embryos were examined by double RNA in situ hybridizations using the myeloid-specific markers l-plastin (lcp=l-pl), 10 myeloperoxidase (mpo), 9 lysozyme C (lys C), 18 macrophage colonystimulating factor receptor (csf1r=c-fms), 19, 20 and CCAAT=enhancer binding protein 1 (c=ebp1). 17 Previous work correlated the appearance of l-pl expression with regions in which macrophages were visualized in live embryos. 10, 20 Further, l-pl has been shown to be coexpressed in at least a subset of cells expressing c=ebp1 17 and lys C, 18 while the majority of mpo-expressing cells were found to be distinct from l-pl. However, further studies to distinguish clearly amongst these multiple subsets have not been performed.
Beginning at approximately 22-24 hpf, two populations of cells could be distinguished by staining with l-pl, c-fms, mpo, and lys C. One population present in both the tail and yolk sac stained with mpo and lys C (Fig. 1C) and did not express l-pl (Fig. 1A, B ) or c-fms (Fig. 1D, E) . The second population, also present in yolk sac and tail, costained with both l-pl and c-fms (Fig.  1F ), but did not stain with lys C or mpo (Fig. 1D,  E) . We conclude that the cells costaining with l-pl and c-fms are likely macrophages given that c-fms is expressed specifically in macrophages in mammals 21 and characterization of macrophages in zebrafish has correlated the movement of these macrophages on video microscopy with the positions of l-pl (þ) cells by RNA in situ hybridization. 10 mpo expression has been demonstrated in adult zebrafish granulocytes by in situ hybridizations in kidney sections. 9 Thus, the mpo (þ)= lys C (þ) population likely marks granulocytes in embryos. While mpo and lys C staining was largely coincident, prior to circulation (between 21 somites and 24 hpf ) there was a population of mpo-staining cells that did not express lys C. Single mpo-expressing cells were in the ICM only ( Fig. 2A) , while double-staining mpo (þ)= lys C (þ) cells were only present over the yolk sac (Fig. 2B ). The population of mpo (þ)=lys C (À) cells in the ICM did not costain with gata1 ( Fig. 2C ) and was therefore clearly distinct from erythroid progenitors. In mammals, myeloperoxidase is a primary granule protein, while lysozyme is found in both primary and secondary granules. We therefore postulate that the single mpo-staining population may represent an earlier step in granulocyte maturation prior to lys C expression.
In a previous work we identified a C=ebp family member expressed only in myeloid cells, which we called c=ebp1.
17 c=ebp1 does not have an ortholog in mammals, but has an identified ortholog in at least one other fish species (GenBank accession no. AB049814). We have shown previously that a subset of cells expressing l-pl coexpress c=ebp1. 17 To determine whether the mpo=lys C doubly positive population expressed c=ebp1, two-color staining in situ hybridizations were performed at 28 hpf with c=ebp1 and lys C. Two-color staining demonstrated coexpression of c=ebp1 with a subset of lys C-expressing cells in the tail (Fig. 2D) and yolk sac (data not shown). Thus, expression of c=ebp1 occurs in a subset of the cells of both the macrophage and granulocyte lineages.
Macrophage development and granulocyte development are differentially affected in pu.1 MO-injected embryos To examine the requirement for Pu.1 in zebrafish primitive myeloid development, pu.1 was targeted in zebrafish embryos using MOs recognizing the pu.1 translation initiation site ( pu.1 init) or the exon 5 splice donor site ( pu.1 ex 5), which is the most proximal exon to the Ets domain, required for Pu.1 function.
To examine the efficacy of the pu.1 ex 5 MO, we analyzed splice products from pu. MO-injected embryos. RNA at 21 somites was harvested from pu.1 ex 5 MO-injected and pu.1 ex 5-misinjected embryos. Polymerase chain reaction (PCR) primers spanning the exon 5 splice donor site were used to amplify pu.1 splice products (Fig. 3A) . Three products were detected from RNA recovered from pu.1 ex 5 MO-injected samples, and sequencing revealed that each product was distinct from the wild-type product amplified from pu.1 ex 5-misinjected or uninjected embryos (Fig. 3A, B ). There were three splice variants utilizing different cryptic splice donors and either the exon 6 splice acceptor or a cryptic acceptor (Fig. 3B,  C) . Each of the products resulted in a predicted translation product lacking the highly conserved Ets-DNA binding domain (Fig. 3C) . Thus, all products would be expected to result in nonfunctional, prematurely truncated proteins. There was no wild-type product detected.
Injection of pu.1 init (data not shown) or pu.1 ex 5 (Fig. 4 ) resulted in complete loss of l-pl in 86% of embryos (n ¼ 82) compared to animals injected with a control, mismatch MO, in which 100% of embryos expressed l-pl ( p < 0.001) (Fig.  4A, B ). There was also loss of myeloid c-fms staining in 100% of injected embryos (n ¼ 38) (Fig. 4D ) compared to controls, which all stained over the yolk sac for c-fms (n ¼ 30; p < 0.001) (Fig. 4C) . Expression of c-fms in previously described nonhematopoietic pigment cells= neural crest cells on the dorsum of the tail 19 was unaffected ( Fig. 4C, D ; arrowheads). Control embryos injected with equal amounts of the negative control MO, pu.1 ex 5 mis (Fig. 4A,  C) , or pu.1 init mis (data not shown) did not affect staining with l-pl or c-fms. The costaining results combined with the pu.1 MO results demonstrated that there was loss of macrophage development in the absence of Pu.1.
While injection of either init or ex 5 pu.1 MO resulted in complete loss of l-pl and c-fms staining, expression of mpo and lys C was unaffected in pu.1 MO-injected embryos ( Fig. 4E -H) in three independent experiments. Only when a combination of the two MOs was injected at a maximal concentration of 0.375 mM pu.1 init and 0.025 mM pu.1 ex 5, was there loss or severe reduction of mpo expression in 92% of embryos (n ¼ 38) and loss or severe reduction in lys C expression in 67% of embryos (n ¼ 45). Injection of higher doses of the combination was toxic, resulting in morphologic abnormalities and lethality (data not shown).
To determine whether the phenotypic changes seen with the MO injections were due to specific loss of Pu.1, rescue experiments with pu.1 mRNA were performed. mRNA synthesized in vitro from pu.1 cDNA will not be recognized by the ex 5 MO since the splice donor site is absent in normally spliced mRNA. Injection of pu.1 ex 5 MO (0.1 mM) with pu.1 mRNA (50 pg) resulted in rescue of l-pl expression in 79% of embryos (n ¼ 85) compared to l-pl expression observed in only 13% of embryos injected with MO alone ( p < 0.001) (Fig. 5A, B) .
To evaluate the function of the transcription factor C=ebp1 in myeloid development, we used two translation initiation site MOs designated c=ebp1.1 and c=ebp1.2. Injection of either MO alone or the combination resulted in significant reduction or absence of lys C expression by 24 hpf in 85% of embryos (n ¼ 79) compared to controls in which lys C expression was positive in 100% of embryos (n ¼ 32) (Fig.  6E, F) . In contrast, l-pl expression and mpo expression were unaffected (Fig. 6A-D) . Further, expression of c=ebp1 itself was significantly reduced or absent in 60-80% of embryos in three independent experiments (Fig. 6G, H) , consistent with a model in which C=ebp1 autoregulates its own expression.
c=ebp1 mRNA (50 pg) lacking the 5 0 untranslated region recognized by both MOs was coinjected with each MO to assess rescue. Rescue was incomplete, with lys C expression in 68% of embryos coinjected with MO and mRNA (n ¼ 25) compared to expression of lys C in 15% of embryos injected with MO alone (n ¼ 79) ( p < 0.001). Injection of higher concentrations of mRNA resulted in gross morphologic abnormalities. It is likely that due to the highly conserved bZIP domain of c=ebp1, which contains the dimerization and DNA binding regions, widespread ectopic expression of c=ebp1 may activate many genes controlled by the other C=ebp family members. In support of this speculation, in previous work it was also not possible to inject gata1 mRNA without encountering toxicity, also likely due to ectopic activation of many Gata-responsive genes. 8 To confirm the results of the c=ebp1 MO knockdown, a g-ray deletion mutant, c1054, which has a deletion in the distal portion of linkage group 24 (M.E. Halpern and A. Fritz, unpublished data), where c=ebp1 was previously mapped, 17 was examined. We analyzed the deleted region in this mutant by amplification from c1054 genomic DNA with primers within c=ebp1 and flanking markers. These data showed that the deleted region occurred distal to 64.5 cM and spanned at least 71-72.1 cM, including deletion of c=ebp1 (Fig. 7A, B) . While multiple genes are likely included in the deleted region, the loss of c=ebp1 provided an opportunity to confirm the MO results in homozygous c1054 mutant embryos.
The mutant embryos displayed normal expression of the macrophage marker c-fms (n ¼ 11) (Fig. 7C, D) and the granulocyte marker mpo (n ¼ 17) (Fig. 7E ), but had little or no expression of lys C (n ¼ 23) (Fig. 7F) , confirming the findings in the c=ebp1 MO-injected embryos. Thus, in the absence of C=ebp1 expression, embryos displayed normal l-pl, c-fms, and mpo expression, allowing us to draw the conclusion that macrophages and granulocytes were present, but either did not express lys C or lacked the granules containing lys C.
Discussion
The use of the zebrafish for dissection of developmental pathways has gained prominence over the past decade. While many mutants affecting erythroid development have been isolated, few mutants with myeloid defects have been identified. 22 Identification of genes expressed in myeloid cells has now allowed the development of myeloid-specific mutagenesis screens, but a detailed understanding of the normal myelopoietic pathway is still lacking.
An issue of great importance to these analyses is the comparison of primitive myeloid development in the zebrafish to the myeloid processes that occur in higher vertebrates. In zebrafish, both granulocytes and macrophages develop between 21 somites (19.5 hpf ) and 3 days postfertilization (dpf ), during the primitive wave of hematopoiesis. 9, 11 The great advantage of zebrafish is the ability to analyze these early developmental events. However, it is unclear how primitive myeloid development in the zebrafish compares to primitive macrophage and, more importantly, definitive myeloid development in higher vertebrates.
Our studies reveal that two distinct myeloid cell types can be distinguished in primitive myelopoiesis by whole-mount RNA in situ hybridization. The mpo=lys C double-staining population labels the neutrophil=heterophil population. In mammals, lysozyme expression has been documented in both granulocytes and macrophages. However, an in vivo tagging study, using a Lysozyme promoter to drive green fluorescent protein (GFP) expression in mice, demonstrated that GFP was most highly expressed in granulocytes, with much lower expression in myelocyte progenitors and monocytic cells. 23 Our findings are consistent with that work, showing that lysozyme is most highly expressed in granulocytes. The l-pl (þ) population in zebrafish has been previously identified as a macrophage population based on correlation of video microscopy findings and l-pl (þ) cells by RNA in situ hybridization. 10, 20 In humans, L-PL is expressed in granulocytes, monocytes=macrophages, lymphocytes, and natural killer cells, and is frequently expressed in both hematopoietic and nonhematopoietic malignant cells. 24 In contrast, C-FMS, encoding the macrophage colonystimulating factor receptor, is expressed specifically in macrophages. 25 The coexpression of c-fms and l-pl, combined with previous work correlating live macrophage movements with in situ findings, 10, 20 demonstrates that the l-pl-expressing cells are likely the monocyte= macrophage population.
We used two different MOs recognizing pu.1 to assess Pu.1 ablation in zebrafish. Either MO singly resulted in complete loss of l-pl and c-fms expression, while mpo expression and lys C expression were maintained, consistent with a specific loss of the macrophage lineage. When both MOs were injected together at the highest dosage possible without nonspecific toxicity, a significant loss of mpo and lys C expression could be achieved. These data suggest that a differential threshold level of Pu.1 is needed for macrophage development and granulocyte development.
A number of studies in mammals have identified graded requirements of Pu.1 for development of hematopoietic lineages. In vivo, two independent Pu.1 null mouse models have been characterized. 26, 27 In both, development of monocyte=macrophages was deficient, while effects on neutrophil development were more varied. Additional work with both models showed that granulocyte commitment and early gene expression, including expression of Mpo, occurred in the absence of Pu.1.
28-30 However, formation of terminally differentiated, functional neutrophils did not occur without Pu.1.
Studies in tissue culture have demonstrated that higher levels of Pu.1 are required for macrophage development than for granulocyte 31 or B-cell development. 32 Our work demonstrates a definite requirement for pu.1 in macrophage development, consistent with both mouse models and in vitro studies. Granulocytes were able to develop in the zebrafish with very low levels of Pu.1 in our studies.
Recent work using a single pu.1 initiation MO in zebrafish embryos demonstrated loss of both macrophage and granulocyte development with a single initiation site MO. 33 It is possible that the differences between our findings and those of Rhodes et al. 33 may be due to greater Pu.1 knockdown using their MO. Interestingly, the translation initiation pu.1 MO used by Rhodes et al. 33 does not target the first initiation ATG as did our init MO, but rather the fifth in-frame ATG. It is possible that translation occurs from some of these more downstream in-frame ATGs, which might have resulted in continued protein expression with our translation initiation site MO.
Our analysis of the function of C=ebp1 demonstrated a role either in expression of lys C or in myeloid development downstream of mpo, but upstream of lys C. c=ebp1 is a myeloidspecific c=ebp without a mammalian ortholog. 17 While orthologs for C=EBPA and C=EBPB have been identified in the zebrafish, a zebrafish ortholog for C=EBPE has not been identified in library screens 16 or analysis of the available genetic databases (S.E. Lyons, unpublished results).
We have postulated that C=ebp1 may perform an analogous function with C=EBPe. In humans and mice, C=EBPe is required for expression of secondary granule genes, as shown both by mouse gene ablation studies [34] [35] [36] and by the naturally occurring human disorder due to mutations in C=EBPe, neutrophil-specific granule deficiency. 35, 37, 38 Myeloperoxidase is an enzyme of primary granules, while lysozyme is an enzyme found in both primary and secondary granules. 39, 40 Additional secondary granule proteins have not yet been identified in zebrafish. Our finding of mpo expression preceding lys C expression in cells in the ICM suggests that these cells may be earlier myeloid progenitors. The isolated loss of lys C expression after C=ebp1 ablation is consistent with a role for C=ebp1 in terminal myeloid differentiation. We can hypothesize that C=ebp1 may regulate lys C or may act upstream of secondary granule formation in granulocytes. The assessment of C=ebp1 function in zebrafish myeloid development suggests that it may play a functionally conserved role with mammalian C=EBPe. 41 Our data show that primitive myeloid development in zebrafish results in at least two myeloid lineages, distinguishable by multiple markers in RNA in situ hybridization. Using pu.1 and c=ebp1 MOs, we have begun to construct the developmental pathways of primitive myeloid development in the zebrafish (Fig. 8) . The function of Pu.1 appears to be highly conserved from mammalian definitive myelopoiesis to zebrafish primitive myelopoiesis. The functions of C=ebp1 may be conserved with mammalian C=EBPe.
These studies demonstrate that zebrafish primitive myeloid development can be used as a model system with direct relevance to human myeloid lineage development. They also reveal the complexity of the myeloid pathway, and the need to tailor mutagenesis screens to identify myeloid mutants. The choice of the myeloidspecific marker used in a mutagenesis screen will determine the genes and specific pathways that will be identified. Identification and characterization of mutants with defects in myeloid marker expression has the potential to identify genes encoding direct upstream regulators of myeloid proteins and effectors of lineagedetermination decisions. Future studies of zebrafish embryonic myelopoiesis will greatly enhance our understanding of the myeloid developmental pathway in vertebrates.
Materials and Methods
Zebrafish maintenance and breeding
Zebrafish were raised and maintained as described previously, 42 with EK strain wild-type fish used for all studies. Embryos older than 24 hpf were treated with 0.003% 1-phenyl-2-thiourea (Sigma, St. Louis, MO) to inhibit pigment formation.
Whole-mount RNA in situ hybridization
Embryos were collected and whole-mount in situ hybridization was performed as previously described 17 with minor modifications. Embryos older than 24 hpf were treated with proteinase K treatment at 10 mg=mL for 5 min, embryos at 2 dpf with 20 mg=mL for 20 min, and embryos at 3-4 dpf with 100 mg=mL for 20 min. Hybridization with probes and the subsequent washes were all performed at 608C.
Antisense RNAs for in situ hybridization were prepared as previously reported for lys C, For two-color staining, in situ hybridization was performed as previously described. 17 For fluorescence two-color staining, embryos were hybridized with both DIG-labeled and FLUORlabeled probes followed by posthybridization incubation with anti-DIG-alkaline phosphatase and anti-FLUOR horseradish peroxidase (HRP) antibodies. 43, 44 Color=fluorescent staining was performed with Fast Red (Roche), which formed a color precipitate that is also visible under fluorescence using a rhodamine filter. The HRPconjugated antibody results in fluorescence detectable with a fluorescein isothiocyanate (FITC) filter using the tyramide signal amplification (TSA)-biotin system (Perkin-Elmer, Waltham, MA). Embryos were visualized on a Leica MZFLIII dissecting microscope and photographed with a Coolsnap digital camera.
MO microinjection
Embryos used for microinjection were obtained from breeding wild-type EK strain zebrafish. The following MOs were created by GENE TOOLS, LLC (Philomath, OR; www .Gene-Tools.com). Lower-case letters designate mismatches, and underscore marks initiation ATG. approximately 1-20 ng). For each MO or MO mix, injection concentrations were titrated to determine the maximal injectable dose with minimal nonspecific morphologic abnormalities. MO concentrations injected were as follows: pu.1 init, 0.75 mM; pu.1 ex 5, 0.1 mM; pu.1 init=ex 5, 0.375 mM=0.025 mM; c=ebp1 init 1=2, 0.25 mM each. The same concentrations of mismatch were used for each corresponding MO. Microinjections were performed according to published protocols 42 using a pneumatic picopump (World Precision Instruments, Sarasota, FL). All results were obtained in at least three independent experiments with at least 20 embryos=MO condition.
Analysis of mRNA splice products
After injection of embryos with pu.1 ex 5 or ex 5 mis MOs, embryos were collected into Trizol (Invitrogen, Carlsbad, CA) at the 21 somite stage. RNA was isolated according to manufacturer's instructions. mRNA was used for a reverse transcriptase reaction using random oligonucleotides as primers followed by PCR using the following primers targeting the pu.1 cDNA between exon 5 and exon 6: For analysis of the deleted region of the c1054 g-ray mutant, genomic DNA from a wild-type control and c1054 were amplified with zmarker primers and primers for c=ebp1 and c=ebpd described previously. 16, 17 mRNA rescue pu.1 and c=ebp1 cDNAs were amplified and subcloned into pCS2þ 45 digested with BamHI and EcoRI. For c=ebp1, the forward primer begins amplification at the ATG, removing the 5 Capped mRNA was synthesized using an mMessage RNA synthesis kit (Ambion, Foster City, CA) as previously described. 46 Embryos were injected at the one-cell stage with appropriate MOs and 50-100 pg of mRNA. Rescue was evaluated by in situ hybridization for rescue of hematopoietic marker expression. Embryos injected with 50-100 pg GFP mRNA were used as negative control embryos.
